Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients

Indian Journal of Leprosy

Volumn 68, Issue 3, 1996, Pages 235-245

  Gallo, M E N ^a   Alvim, M F S ^a   Nery, J A C ^a   Albuquerque, E C A ^a   Sarno, E N ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANIMALS; CLOFAZIMINE; DAPSONE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPROSTATIC AGENTS; LEPROSY, BORDERLINE; LEPROSY, LEPROMATOUS; MALE; MICE; MIDDLE AGED; RETROSPECTIVE STUDIES; RIFAMPIN; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 0029843586     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Andrade VLG, Boechat AM, Viana FR et al 1993. Estudo do índice baciloscópico em pacientes de Hanseníase Multibacilares durante tratamento com esquema MDT/OMS e no período de dois anos após a interrupção da terapêutica. An Bras Dermatol 68:191-193.
2. Becx-Bleumink M, Berhe D 1992. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the Leprosy Control Program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int J Lepr 60:173-184.
3. Becx-Bleumink M 1994. Success of the WHO multidrug therapy? Trop Geograph Med 46:61-64.
4. Brazil 1994. National Coordination Sanitary Dermatology of the Ministry of Health, Brasília.
5. Bullock WE 1983. Rifampicin in the treatment of leprosy. Rev Infect Dis 5:600-613.
6. Castro IM 1978. Adaptação do método de controle da sulfonúria. Bol Div Nac Dermatol Sanitaria 43-44.
7. Cellona RV, Fajardo Jr TT, Kim D et al 1990. Joint chemotherapy trials in lepromatous leprosy conducted in Thailand, the Philippines and Korea. Int J Lepr 58:1-11.
8. Dean AG, Dean JA, Dicker RC 1990. EpiInfo version 5:1 word processing, database and statistics program for epidemiology on microcomputers, ESD, Inc. Stone Mountain, Georgia (USA).
9. Ganapati R, Pai R, Gandewar KL, Thressia XJ 1989. For how long should a multibacillary leprosy patient be treated? Indian J Lepr 61:467-471.
10. Huang-Yng L, Xio-Lu Y, Mao-Sheng Z et al 1989. Short-term multidrug therapy in multibacillary leprosy - Review of 80 cases in two provinces of China (1983-1988). Int J Lepr 57:622-627.
11. Irudayaraj P, Aschhoff M 1989. Assessment criteria and multidrug therapy. Int J Lepr 57 (Suppl):426.
12. Jakeman P, Smith WCS 1994. Evaluation of a MDT programme of leprosy control. Lepr Rev 65:467-471.
13. Nery JAC 1995. Reação na Hanseníase: uma descrição epidemiológica. UFF, Rio de Janeiro, 129f. Tese para obtenção do título de Mestre em Dermatologia.
14. Opromolla DVA, Tonello CJS, McDougall AC et al 1981. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy. Int J Lepr 49:393-396.
15. Pattyn SR, Bourland J, Grillone S et al 1989. Combined regimens of one year duration in the treatment of multibacillary leprosy - I. Combined regimens with rifampicin adminstered during one year. Lepr Rev 60:109-117.
16. Pattyn SR, Bourland J, Kazeze Y 1992. Ambulatory treatment of multibacillary leprosy with a regimen of 8 months duration. Lepr Rev 63:36-40.
17. Rao PS, Reddy BN, Krishnamurthy P et al 1992. Initial intensive therapy for multibacillary leprosy patients in retrospect. Lepr Rev 63:350-357.
18. Ridley DS 1964. Bacterial indices. Leprosy in theory and practice, appendix III. eds Cochrane RG, Davey T. Edn 2, John Wright, Bristol.
19. Ridley DS, Jopling WH 1966. Classification of leprosy according to immunity: a five group system. Int J Lepr 34:255-273.
20. Shepard AC 1960. The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. J Exp Med 112:445-454.
21. THELEP 1989. Subcommittee on clinical trials, scientific working group on the chemotherapy of leprosy (THELEP). Response of THELEP trial patients to combined drug regimens. Int J Lepr 57:428 (Abstract).
22. Waters MFR, Rees RJW 1962. Changes in the morphology of M. leprae in patients under treatment. Int J Lepr 36:266-272.
23. WHO 1977. Standard protocol for chemotherapy trials in lepromatous leprosy. World Health Organization, Geneva. TDR/SWG THELEP 1:77-83.
24. WHO 1982. Chemotherapy of leprosy for control programmes. WHO Tech Rep Ser 675.
25. WHO 1988. WHO Expert Committee on leprosy, Sixth Report. WHO Tech Rep Ser 768.
26. WHO 1994. Chemotherapy of leprosy. WHO Tech Rep Ser 847.